Author
Listed:
- Nariman A. Balenga
(Molecular Signal Transduction Section, Laboratory of Allergic Diseases, NIAID/NIH
Present address: Division of General & Oncologic Surgery, Department of Surgery University of Maryland, School of Medicine 655 W. Baltimore St., Room 10-010 Baltimore, Maryland 21201, USA.)
- Michael Klichinsky
(Pulmonary, Airways Biology Initiative, University of Pennsylvania)
- Zhihui Xie
(Molecular Signal Transduction Section, Laboratory of Allergic Diseases, NIAID/NIH)
- Eunice C. Chan
(Molecular Signal Transduction Section, Laboratory of Allergic Diseases, NIAID/NIH)
- Ming Zhao
(Protein Chemistry, Research Technologies Branch, Twinbrook I)
- Joseph Jude
(Pulmonary, Airways Biology Initiative, University of Pennsylvania)
- Michel Laviolette
(Institut universitaire de cardiologie et pneumologie de Québec (Laval University))
- Reynold A. Panettieri
(Pulmonary, Airways Biology Initiative, University of Pennsylvania)
- Kirk M. Druey
(Molecular Signal Transduction Section, Laboratory of Allergic Diseases, NIAID/NIH)
Abstract
Asthma, a common disorder that affects >250 million people worldwide, is defined by exaggerated bronchoconstriction to inflammatory mediators including acetylcholine (ACh), bradykinin and histamine—also termed airway hyper-responsiveness. Nearly 10% of people with asthma have severe, treatment-resistant disease, which is frequently associated with immunoglobulin-E sensitization to ubiquitous fungi, typically Aspergillus fumigatus (Af). Here we show that a major Af allergen, Asp f13, which is a serine protease, alkaline protease 1 (Alp 1), promotes airway hyper-responsiveness by infiltrating the bronchial submucosa and disrupting airway smooth muscle (ASM) cell-extracellular matrix (ECM) interactions. Alp 1-mediated ECM degradation evokes pathophysiological RhoA-dependent Ca2+ sensitivity and bronchoconstriction. These findings support a pathogenic mechanism in asthma and other lung diseases associated with epithelial barrier impairment, whereby ASM cells respond directly to inhaled environmental allergens to generate airway hyper-responsiveness.
Suggested Citation
Nariman A. Balenga & Michael Klichinsky & Zhihui Xie & Eunice C. Chan & Ming Zhao & Joseph Jude & Michel Laviolette & Reynold A. Panettieri & Kirk M. Druey, 2015.
"A fungal protease allergen provokes airway hyper-responsiveness in asthma,"
Nature Communications, Nature, vol. 6(1), pages 1-13, November.
Handle:
RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms7763
DOI: 10.1038/ncomms7763
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms7763. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.